Pharmaceutical Manufacturer

From June 5 to August 4, Canadians can share their thoughts with the federal task force for drug shortages.

Bipolar disorder is a chronic condition that requires life-long therapy in most patients in order to prevent relapses.

The report notes a “significant increase” in antidepressants by plan members under 19, as well at other notable movements in drugs for ADHD, diabetes and children.

Arun Crishanth said the cost of Deflazacort, a medication he has taken for over a decade, has increased by more than $1,400 a year.

The NDP and Liberals struck a confidence-and-supply agreement last year that would see the NDP support the government on key votes to hold an election off until 2025 in exchange for progress on NDP priorities.

Emails released to the House of Commons committee on health suggest some on the regulator’s board believed the crisis that followed the minister’s letter threatened the very survival of the agency.

Emails released to the House of Commons committee on health suggest some on the regulator’s board believed the crisis that followed the minister’s letter threatened the very survival of the agency.

Real-world evidence is becoming increasingly important. New guidance from Health Canada and the Canadian Agency for Drugs and Technologies in Health shares how it can be best used.